By Chris Wack Legend Biotech said its Legend Biotech Ireland subsidiary has entered into an exclusive, global license agreement for LB2102 with Novartis.
By Pierre Bertrand Novartis said the U.S. Food and Drug Administration has approved its drug Cosentyx for the treatment of the hidradenitis suppurativa skin.
By Adria Calatayud Novartis raised its full-year earnings guidance for the third time this year after it reported higher net profit and sales for the third.
By Adria Calatayud Novartis raised its full-year earnings guidance for the third time this year after it reported higher net profit and sales for the third.
The Swiss pharmaceutical company says its transition to a pure-play innovative medicines business is now complete following the spinoff of Sandoz, its.